生命最初1000天诊断的CAKUT患者全外显子测序诊断率与获益
本研究对100例在生命最初1000天诊断且CKD分期1至5D/T的CAKUT患者行全外显子测序,提取58个已知CAKUT相关基因变异并按ACMG指南分类。25%患者检出罕见可能致病或致病变异,需3岁前KRT者诊断率43%(OR 2.95)、伴肾外特征者41%(OR 3.5)显著更高,25%患者遗传诊断促成预防措施和/或早期治疗。
要点
- 100例早期诊断CAKUT患者中25%检出可能致病或致病变异。
- 3岁前需KRT者诊断率43%(OR 2.95),伴肾外特征者41%(OR 3.5)。
- 25%患者遗传诊断促成预防措施和/或早期治疗。
核心结论
- WES对3岁前诊断的CAKUT患者诊断和管理有显著优势,尤其需KRT或伴肾外异常者。
研究设计与样本
- 对100例生命最初1000天诊断、CKD分期1至5D/T的CAKUT患者行全外显子测序。
- 提取58个已知CAKUT相关基因变异,按ACMG指南分类并评估转化价值。
主要发现
- 25%患者(多为散发性)在15个CAKUT相关基因中的1或2个检出罕见可能致病或致病变异。
- 检出27个变异中52%为功能丧失变异,18.5%为新生变异。
- 需3岁前KRT者诊断率43%(OR 2.95),显著高于无此标准者。
- 伴肾外特征者诊断率41%(OR 3.5),显著高于无此标准者。
- 25%患者因遗传诊断得以采取预防措施和/或早期治疗。
临床怎么用
- 对3岁前诊断的CAKUT患者,尤其需KRT或伴肾外异常者,WES可提供诊断和管理优势。
- 检出基因均与肾外并发症相关,包括可治疗的糖尿病、高尿酸血症、低镁血症和甲状旁腺功能减退症。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on average, in only 16% of unselected CAKUT cases, making genetic testing unproductive. METHODS: Whole exome sequencing (WES) was performed in 100 patients with CAKUT diagnosed in the first 1000 days of life with CKD stages 1 to 5D/T. Variants in 58 established CAKUT-associated genes were extracted, classified according to the American College of Medical Genetics and Genomics guidelines, and their translational value was assessed. RESULTS: In 25% of these mostly sporadic patients with CAKUT, a rare likely pathogenic or pathogenic variant was identified in 1 or 2 of 15 CAKUT-associated genes, including GATA3, HNF1B, LIFR, PAX2, SALL1, and TBC1D1. Of the 27 variants detected, 52% were loss-of-function and 18.5% de novo variants. The diagnostic yield was significantly higher in patients requiring KRT before 3 years of age (43%, odds ratio 2.95) and in patients with extrarenal features (41%, odds ratio 3.5) compared with patients lacking these criteria. Considering that all affected genes were previously associated with extrarenal complications, including treatable conditions, such as diabetes, hyperuricemia, hypomagnesemia, and hypoparathyroidism, the genetic diagnosis allowed preventive measures and/or early treatment in 25% of patients. CONCLUSION: WES offers significant advantages for the diagnosis and management of patients with CAKUT diagnosed before 3 years of age, especially in patients who require KRT or have extrarenal anomalies.
引用
- Werfel L, Martens H, Hennies I, et al. Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life. Kidney Int Rep. 2023. PMID: 38025229. doi:10.1016/j.ekir.2023.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。